Cerium Oxide Nanoparticles Alleviate Neuropathic Pain by Modulating Macrophage Polarization in a Rat SCI Model
DOI: https://doi.org/10.2147/JPR.S371789
IF: 2.8319
2022-10-25
Journal of Pain Research
Abstract:Dexiang Ban, 1, 2, &ast Hao Yu, 1, 2, &ast Zhenyang Xiang, 1, 2, &ast Chao Li, 1, 2 Peng Yu, 1, 2 Jianhao Wang, 1, 2 Yang Liu 1, 2 1 Department of Orthopaedic, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China; 2 International Science and Technology Cooperation Base of Spinal Cord Injury, Tianjin Key Laboratory of Spine and Spinal Cord Injury, Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yang Liu, Department of Orthopaedic, Tianjin Medical University General Hospital, Anshan Road No. 154, Heping District, Tianjin, 300052, People's Republic of China, Email Context: Chronic neuropathic pain (NP) frequently occurs after spinal cord injury (SCI) but lacks effective therapeutic options in the clinic. Numerous evidence indicates the involvement of macrophages activation in the NP, and the modulation of macrophages is promising for NP treatment. In this study, we introduce Cerium oxide nanoparticles (CONPs) and aim to investigate whether it can relieve the NP by modulating macrophage polarization. Methods: CONPs were prepared using the hydrothermal method. In vitro, different concentrations of CONPs were used to cultivate macrophages (RAW 264.7). In vivo, the analgesic effect of CONPs was investigated in a contusive rat SCI model. Mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL) were tested to evaluate pain behaviors. Immunofluorescence staining and real-time quantitative polymerase chain reaction were applied to assess macrophage phenotypes. Results: The synthesized CONPs were 6.8 ± 0.5 nm in size, presenting a cubic morphology. Live/dead staining showed that the relatively low concentrations of CONPs (less than 800 μg/mL) displayed good biocompatibility with macrophages. Intrathecal injection of CONPs could significantly increase the mechanical PWT and thermal PWL of SCI rats. Molecular experiments results showed the expression of M2 macrophage-related markers (CD206, Arg-1, IL-10) were significantly increased, while that of M1 macrophage-related markers (CD86, TNF-α, iNOS) were downregulated after CONPs treatment. Conclusion: Our study suggests that CONPs can relive the NP following SCI by promoting M2 macrophages polarization, which provides a novel insight for the treatment of SCI induced NP. Keywords: cerium oxide nanoparticles, spinal cord injury, neuropathic pain, neuroimmune, macrophages polarization Nearly 68% of the patients with spinal cord injury (SCI) will develop chronic neuropathic pain (NP). The pain can lead to anxiety, depression, and sleep disturbance, greatly reducing the patient's quality of life and increasing the risk of suicide. 1,2 Instead of recovering their walking abilities, the priority of many SCI patients is reliving the NP. However, this need is largely unmet in the clinic. The existing therapeutic strategies usually behave poorly and are often accompanied by some side effects. 3 Therefore, it is necessary to explore more effective interventions for SCI-induced NP management. Many studies have highlighted the importance of the neuroimmune mechanism underlying NP pathogenesis. The persistent interactions between the immune and nervous systems trigger neuroinflammation, eliciting ectopic neuronal activity and resulting in the NP. 4,5 Macrophages are the main immune cells and have a significant function in mediating neuroinflammation. They are highly plastic and can polarize into the classical phenotype (M1) and the alternative phenotype (M2). M1 macrophages can exacerbate the inflammatory responses while M2 macrophages pose anti-inflammatory properties. Modulating the polarization of the macrophage can greatly influence the inflammation processes and has been seen as a promising strategy for NP treatment. 6–8 Cerium oxide nanoparticles (CONPs) are redox-active rare earth nanomaterials. It has shown many fascinating biological properties such as anti-inflammation, anti-oxidation, anti-tumor, as well as free radical scavenging, and attracts increased interest for therapeutic application. 9–12 Some studies have reported the analgesic effect of CONPs in the animal model of spinal nerve injury and diabetic neuropathy. 13,14 Recently, a study revealed that CONPs could alleviate nociceptive behaviors by inhibiting macrophage activation in the injured sites. 15 The further molecular analysis indicated that after CONPs -Abstract Truncated-
clinical neurology